The role of alpha lipoic acid in female and male infertility: a systematic review

References

• Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril. 2012;98:302–307.
   PubMed Web of Science ®Google Scholar
• Mazzilli R, Cimadomo D, Vaiarelli A, et al. Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cycles. Fertil Steril. 2017;108(6):961–972.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Gupta S, Sekhon L, et al. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008;10(8):1375–1403.
   PubMed Web of Science ®Google Scholar
• Du Plessis SS, Makker K, Desai NR, et al. Impact of oxidative stress on IVF. Expert Rev Obstet Gynecol. 2008;3(4):539–554.
   Google Scholar
• Taylor CT. Antioxidants and reactive oxygen species in human fertility. Environ Toxicol Pharmacol. 2001;10(4):189–198.
   PubMed Web of Science ®Google Scholar
• Taleb A, Zavareh S, Kashani MH, et al. The effect of alpha lipoic acid on the developmental competence of mouse isolated preantral follicles. J Assist Reprod Genet. 2012;29(2):175–183.
   PubMed Web of Science ®Google Scholar
• Zavareh S, Rahnama A, Karimi I, et al. Effect of in vitro maturation technique and alpha lipoic acid supplementation on oocyte maturation rate: focus on oxidative status of oocytes. Int J Fertil Steril. 2016;9:442–451.
   PubMed Web of Science ®Google Scholar
• Rago R, Marcucci I, Leto G, et al. Effect of myo-inositol and alphalipoic acid on oocyte quality in polycystic ovary syndrome non-obese women undergoing in vitro fertilization: a pilot study. J Biol Regul Homeost Agents. 2015;29:913–924.
   PubMed Web of Science ®Google Scholar
• Muzii L, Di Tucci C, Di Feliciantonio M, et al. Management of endometriosis from diagnosis to treatment: roadmap for the future. Minerva Ginecol. 2019;71(1):54–61.
   PubMed Web of Science ®Google Scholar
• Collinet P, Decanter C, Lefebvre C, et al. [Endometriosis and infertility]. Gynecol Obstet Fertil. 2006;34(5):379–384.
   PubMedGoogle Scholar
• Christodoulakos G, Augoulea A, Lambrinoudaki I, et al. Pathogenesis of endometriosis: the role of defective 'immunosurveillance'. Eur J Contracept Reprod Health Care. 2007;12(3):194–202.
   PubMed Web of Science ®Google Scholar
• Augoulea A, Mastorakos G, Lambrinoudaki I, et al. The role of the oxidative-stress in the endometriosis-related infertility. Gynecol Endocrinol. 2009;25(2):75–81.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:28.
   PubMed Web of Science ®Google Scholar
• Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what’s new? Adv Clin Exp Med. 2017;26(2):359–367.
   PubMed Web of Science ®Google Scholar
• Agostinis C, Zorzet S, De Leo R, et al. The combination of N-acetyl cysteine, alpha-lipoic acid, and bromelain shows high anti-inflammatory properties in novel in vivo and in vitro models of endometriosis . Mediators Inflamm. 2015;2015:918089.
   PubMed Web of Science ®Google Scholar
• Caruso S, Iraci Sareri M, Casella E, et al. Chronic pelvic pain, quality of life and sexual health of women treated with palmitoylethanolamide and a-Lipoic acid. Minerva Ginecol. 2015; 67:413–419.
   PubMed Web of Science ®Google Scholar
• Lete I, Mendoza N, de la Viuda E, et al. Effectiveness of an antioxidant preparation with N-acetyl cysteine, alpha lipoic acid and bromelain in the treatment of endometriosis­associated pelvic pain: LEAP study. Eur J Obstet Gynecol Reprod Biol. 2018; 228:221–224.
   PubMed Web of Science ®Google Scholar
• De Leo V, Cagnacci A, Cappelli V, et al. Role of a natural integrator based on lipoic acid, palmitoiletanolamide and myrrh in the treatment of chronic pelvic pain and endometriosis. Minerva Ginecol. 2019;71(3):191–195.
   PubMed Web of Science ®Google Scholar
• Wahl KJ, Orr NL, Lisonek M, et al. Deep dyspareunia, superficial dyspareunia, and infertility concerns among women with endometriosis: a cross-sectional study. Sex Med. 2020;8:274–281.
   PubMed Web of Science ®Google Scholar
• Murina F, Graziottin A, Felice R, et al. Alpha lipoic acid plus omega-3 fatty acids for vestibulodynia associated with painful bladder syndrome. J Obstet Gynaecol Can. 2017;39(3):131–137.
   PubMed Web of Science ®Google Scholar
• Fauser BC. Reproductive endocrinology: revisiting ovulation induction in PCOS. Nat Rev Endocrinol. 2014;10(12):704–705.
   PubMed Web of Science ®Google Scholar
• Adams J, Liu Z, Ren YA, et al. Enhanced inflammatory transcriptome in the granulosa cells of women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2016;101(9):3459–3468.
   PubMed Web of Science ®Google Scholar
• Seyam E, Hefzy E. Evaluation of the correlation between insulin like factor 3, polycystic ovary syndrome, and ovarian maldescent. Gynecol Endocrinol. 2018;34(6):481–488.
   PubMed Web of Science ®Google Scholar
• Boots CE, Jungheim EF. Inflammation and human ovarian follicular dynamics. Semin Reprod Med. 2015;33(4):270–275.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
   PubMed Web of Science ®Google Scholar
• Papalou O, Victor VM, Diamanti-Kandarakis E. Oxidative stress in polycystic ovary syndrome. Curr Pharm Des. 2016;22(18):2709–2722.
   PubMed Web of Science ®Google Scholar
• Zuo T, Zhu M, Xu W. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev. 2016;2016:8589318.
   PubMed Web of Science ®Google Scholar
• Masharani U, Gjerde C, Evans JL, et al. Effects of controlled-release alpha lipoic acid in lean, non-diabetic patients with polycystic ovary syndrome. J Diabetes Sci Technol. 2010;4(2):359–364.
   PubMedGoogle Scholar
• Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.
   PubMed Web of Science ®Google Scholar
• Sabuncu T, Vural H, Harma M, et al. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001;34(5):407–413.
   PubMed Web of Science ®Google Scholar
• Homburg R. Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):773–788.
   PubMed Web of Science ®Google Scholar
• Costello MF, Misso ML, Wong J, et al. The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol. 2012;52(4):400–403.
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Streicher P, Wang P. Treatment of polycystic ovary syndrome with insulin-lowering agents. Expert Opin Pharmacother. 2002;3(8):1177–1189.
   PubMedGoogle Scholar
• Bargiota A, Diamanti-Kandarakis E. The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Ther Adv Endocrinol Metab. 2012;3(1):27–47.
   PubMedGoogle Scholar
• Palomba S, Falbo A, Zullo F, et al. Jr Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009;30(1):1–50.
   PubMed Web of Science ®Google Scholar
• Genazzani AD. Inositol as putative integrative treatment for PCOS. Reprod Biomed Online. 2016;33(6):770–780.
   PubMed Web of Science ®Google Scholar
• Di Paolo G, Di Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature. 2006;443(7112):651–657. 12
   PubMed Web of Science ®Google Scholar
• Golbidi S, Bradan M, Laher I. Diabets and alpha lipoic acid. Front Pharmac. 2011; 2:69.
   PubMed Web of Science ®Google Scholar
• Shay KP, Moreau RF, Smith EJ, et al. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta. 2009;1790(10):1149–1160.
   PubMed Web of Science ®Google Scholar
• Shen QW, Zhu MJ, Tong J, et al. Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes. Am J Physiol Cell Physiol. 2007;293(4):C1395–403.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Song KH, Koh EH, et al. Alpha-lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem Biophys Res Commun. 2005;332(3):885–891.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Despini G, Santagni S, et al. Effects of a combination of alpha lipoic acid and myo-inositol on insulin dynamics in overweight/obese patients with PCOS. Endocrinol Metab Syndr. 2014;3(3):140.
   Google Scholar
• Cianci A, Panella M, Fichera M, et al. D-Chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in womenwith PCOS. Gynecol Endocrinol. 2015;31(6):483–486.
   PubMed Web of Science ®Google Scholar
• De Cicco S, Immediata V, Romualdi D, et al. Myoinositol combined with alpha-lipoic acid may improve the clinical and endocrine features of polycystic ovary syndrome through an insulin-independent action. Gynecol Endocrinol. 2017;33(9):698–701.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Shefer K, Della Casa D, et al. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. J Endocrinol Invest. 2018;41(5):583–590.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Prati A, Marchini F, et al. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both. Gynecol Endocrinol. 2019;35(12):1088–1093.
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Capozzi A, Canu A, et al. Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome. Gynecol Endocrinol. 2019;35(6):506–510.
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Fidecicchi T, Palla G, et al. Long-term treatment with a-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome. Gynecol Endocrinol. 2020;36(2):152–155.
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Benelli E, Fidecicchi T, et al. Clinical and metabolic effects of alpha-lipoic acid associated with two different doses of Myo-inositol inwomen with polycystic ovary syndrome. Int J Endocrinol . 2020;2020:1–8.
   Web of Science ®Google Scholar
• Cirillo F, Catellani C, Lazzeroni P, et al. HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA). Gynecol Endocrinol. 2020;13:1–6.
   Google Scholar
• Artini PG, Obino MER, Micelli E, et al. Effect of d-chiro­inositol and alpha-lipoic acid combination on COH outcomes in overweight/obese PCOS women. Gynecol Endocrinol. 2020;11:1–5.
   Google Scholar
• Canepa P, Dal Lago A, De Leo C, et al. Combined treatment with myo-inositol, alpha-lipoic acid, folic acid and vitamins significantly improves sperm parameters of sub-fertile men: a multi-centric study. Eur Rev Med Pharmacol Sci. 2018;22(20):7078–7085.
   PubMed Web of Science ®Google Scholar
• Ibrahim SF, Osman K, Das S, et al. Rahman MP A study of the antioxidant effect of alpha lipoic acids on sperm quality. Clinics (Sao Paulo). 2008;63(4):545–550.
   PubMed Web of Science ®Google Scholar
• Haghighian HK, Haidari F, Mohammadi-Asl J, et al. Randomized, triple-blind, placebo-controlled clinical trial examining the effects of alpha-lipoic acid supplement on the spermatogram and seminal oxidative stress in infertile men. Fertil Steril. 2015;104(2):318–324.
   PubMed Web of Science ®Google Scholar
• Rago R, Gallo M, Dal Lago A, et al. Controlled, prospective, observational study on the efficiency and tolerability of a combination of potential Nrf2-inducing antioxidants and micronutrients as pre-treatment for ICSI in dyspermic patients with previous failure. Eur Rev Med Pharmacol Sci. 2017;21(7):1645–1652.
   PubMed Web of Science ®Google Scholar
• Taherian SS, Khayamabed R, Tavalaee M, et al. Alpha-lipoic acid minimises reactive oxygen species-induced damages during sperm processing. Andrologia. 2019;51(8):e13314.
   PubMed Web of Science ®Google Scholar
• Corrêa LBNS, da Costa CAS, Ribas JAS, et al. Antioxidant action of alpha lipoic acid on the testis and epididymis of diabetic rats: morphological, sperm and immunohistochemical evaluation. Int Braz J Urol. 2019;45(4):815–824.
   PubMed Web of Science ®Google Scholar
• Dong L, Zhang X, Yang F, et al. Effect of oral alpha-lipoic acid (ALA) on the treatment of male infertility: a protocol for systematic review and meta-analysis. Medicine (Baltimore). 2019;98(51):e18453
   PubMed Web of Science ®Google Scholar
• Pereira S, Park E, Moore J, et al. Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo. Appl Physiol Nutr Metab. 2015;40(11):1129–1136.
   PubMed Web of Science ®Google Scholar
• Zeng L, Yang K. Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis. Endocrine. 2018;59(1):30–38.
   PubMed Web of Science ®Google Scholar
• Shen D, Wang F, Jiang Z, et al. [Long-term effects of polycystic ovary syndrome on the offspring]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017;46(3):300–304.
   PubMedGoogle Scholar
• Marshall JC, Dunaif A. Should all women with PCOS be treated for insulin resistance? Fertil Steril. 2012;97(1):18–22.
   PubMed Web of Science ®Google Scholar
• Kataoka J, Tassone EC, Misso M, et al. Weight management interventions in women with and without PCOS: a systematic review. Nutrients. 2017;9(9):996.
   Web of Science ®Google Scholar
• Tuncer AA, Bozkurt MF, Koken T, et al. The protective effects of alpha-lipoic acid and coenzyme Q10 combination on ovarian ischemia-reperfusion injury: an experimental study. Adv Med. 2016;2016:3415046–3415017.
   PubMedGoogle Scholar
• Rochette L, Ghibu S, Muresan A, et al. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol. 2015;93(12):1021–1027.
   PubMed Web of Science ®Google Scholar
• Petronilho F, Florentino D, Danielski LG, et al. Alpha-lipoic acid attenuates oxidative damage in organs after sepsis. Inflammation. 2016;39(1):357–365.
   PubMed Web of Science ®Google Scholar
• Hiller S, DeKroon R, Hamlett ED, et al. Alpha-lipoic acid supplementation protects enzymes from damage by nitrosative and oxidative stress. Biochim Biophys Acta. 2016;1860(1 Pt A):36–45.
   PubMed Web of Science ®Google Scholar
• Di Tucci C, Di Feliciantonio M, Vena F, et al. Alpha lipoic acid in obstetrics and gynecology. Gynecol Endocrinol. 2018;34(9):729–733.
   PubMed Web of Science ®Google Scholar
• Sirois J, Sayasith K, Brown KA, et al. Cyclooxygenase-2 and its role in ovulation: a 2004 account. Hum Reprod Update. 2004;10(5):373–385.
   PubMed Web of Science ®Google Scholar
• Gonzalez F, Mather K, Considine R, et al. Suppression of nutrient-induced inflammation with a nonsteroidal anti-inflammatory agent ameliorates ovarian dysfunction in lean insulin-sensitive women with polycystic ovary syndrome (PCOS). Fertil Steril. 2015;104(3):e21.
   Web of Science ®Google Scholar
• Gambineri A, Laudisio D, Marocco C, et al. Female infertility: which role for obesity? Int J Obes Suppl. 2019;9:65–72.
   PubMedGoogle Scholar
• Kelly CCJ, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453–2455.
   PubMed Web of Science ®Google Scholar